Skip to main content
. 2013 Jun 28;18(7):865–875. doi: 10.1634/theoncologist.2013-0095

Table 3.

Prevalence of RET rearrangements in non-small cell lung cancer screening studies

graphic file with name onc00713-1365-t03.jpg

aAll screened specimens were adenocarcinomas with prior negative testing for alterations in EGFR or ALK.

bAll screened specimens were adenocarcinomas.

cAll screened specimens were adenocarcinomas derived from never-smokers.

dSubset of screened specimens derived from individuals of European ancestry (n = 121) or Asians (n = 405) who were never or limited former smokers.

eScreened specimens were adenocarcinomas with prior negative testing for alterations in EGFR, ALK, KRAS, BRAF, MEK1, and HER2.

Abbreviations: FISH, fluorescence in situ hybridization; IHC, immunohistochemistry; RT-PCR, reverse transcription polymerase chain reaction.